“…Aggressive mosquito control campaigns employed physical and chemical engineering to dramatically reduce human disease burden by the late 1960s [3,5,6], but many regions have experienced a (re)emergence of mosquito-vectored diseases, both due to novel pathogens and those previously eradicated [6,7]. This phenomenon has been particularly evident in the increase in human cases of dengue virus (Family Flaviviridae, Genus Flavivirus ), West Nile virus (WNV, Family Flaviviridae, Genus Flavivirus ), La Crosse virus (LACV, Family Bunyaviridae , Genus Orthobunyavirus ), and chikungunya virus (Family Togaviridae , Genus Alphavirus ) among urban populations across the World [4,8,9,10,11,12,13]. The burden of mosquito-vectored disease is centered in developing regions, but developed nations and modern health care systems have not been spared.…”